COVID-19 mRNA Vaccines and Interstitial Lung Disease Exacerbation: Causation or Just a Temporal Association?
作者信息
Ehteshami-Afshar Solmaz, Raj Rishi
机构信息
Stanford University School of Medicine Stanford, California.
出版信息
Am J Respir Crit Care Med. 2022 Oct 1;206(7):919. doi: 10.1164/rccm.202205-0902LE.
Abstract
摘要
相似文献
1
COVID-19 mRNA Vaccines and Interstitial Lung Disease Exacerbation: Causation or Just a Temporal Association?
Am J Respir Crit Care Med. 2022 Oct 1;206(7):919. doi: 10.1164/rccm.202205-0902LE.
2
Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination.
Int J Infect Dis. 2022 Mar;116:255-257. doi: 10.1016/j.ijid.2022.01.031. Epub 2022 Jan 19.
3
Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection.
Infection. 2022 Jun;50(3):791-793. doi: 10.1007/s15010-021-01729-z. Epub 2021 Dec 2.
4
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine.
Lancet Microbe. 2022 Aug;3(8):e561. doi: 10.1016/S2666-5247(22)00150-1. Epub 2022 May 31.
5
Urticarial vasculitis triggered by SARS-CoV-2 vaccine (mRNA vaccine).
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e743-e744. doi: 10.1111/jdv.18253. Epub 2022 Jun 3.
6
Comment on D'Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800-1806.
Diabetes. 2022 Sep 1;71(9):e13. doi: 10.2337/db22-0468.
7
COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease.
Gastroenterology. 2022 Mar;162(3):987-988. doi: 10.1053/j.gastro.2021.10.004. Epub 2021 Oct 6.
8
A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients.
Kidney Int. 2022 Apr;101(4):825-826. doi: 10.1016/j.kint.2022.01.017. Epub 2022 Feb 12.
9
Response to Comment on D'Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800-1806.
Diabetes. 2022 Sep 1;71(9):e14. doi: 10.2337/dbi22-0020.
10
Acquired hemophilia A with SARS-CoV-2 mRNA vaccine: first case from Pakistan.
Scand J Clin Lab Invest. 2022 Sep;82(5):432-434. doi: 10.1080/00365513.2022.2092902. Epub 2022 Jun 29.
引用本文的文献
1
Interstitial lung disease following COVID-19 vaccination: a disproportionality analysis using the Global Scale Pharmacovigilance Database (VigiBase).
BMJ Open Respir Res. 2023 Dec 11;10(1):e001992. doi: 10.1136/bmjresp-2023-001992.
2
COVID-19 in Patients with Chronic Lung Disease.
Clin Chest Med. 2023 Jun;44(2):385-393. doi: 10.1016/j.ccm.2022.11.013. Epub 2022 Nov 22.
本文引用的文献
1
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2022 Jul 15;206(2):219-221. doi: 10.1164/rccm.202112-2765LE.
2
COVID-19 vaccine-associated organizing pneumonia.
Respirol Case Rep. 2022 Mar 29;10(5):e0944. doi: 10.1002/rcr2.944. eCollection 2022 May.
3
COVID-19 mRNA vaccine-related interstitial lung disease: Two case reports and literature review.
Respirol Case Rep. 2022 Mar 23;10(4):e0938. doi: 10.1002/rcr2.938. eCollection 2022 Apr.
4
Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination.
Int J Infect Dis. 2022 Mar;116:255-257. doi: 10.1016/j.ijid.2022.01.031. Epub 2022 Jan 19.
5
A case of severe interstitial lung disease after COVID-19 vaccination.
QJM. 2022 Jan 5;114(11):805-806. doi: 10.1093/qjmed/hcab263.
Zotero 插件